Matches in Wikidata for { <http://www.wikidata.org/entity/Q43654264> ?p ?o ?g. }
- Q43654264 description "2013 nî lūn-bûn" @default.
- Q43654264 description "2013年の論文" @default.
- Q43654264 description "2013年学术文章" @default.
- Q43654264 description "2013年学术文章" @default.
- Q43654264 description "2013年学术文章" @default.
- Q43654264 description "2013年学术文章" @default.
- Q43654264 description "2013年学术文章" @default.
- Q43654264 description "2013年學術文章" @default.
- Q43654264 description "2013年學術文章" @default.
- Q43654264 description "2013年學術文章" @default.
- Q43654264 description "2013年學術文章" @default.
- Q43654264 description "2013年學術文章" @default.
- Q43654264 description "2013年學術文章" @default.
- Q43654264 description "2013년 논문" @default.
- Q43654264 description "article científic" @default.
- Q43654264 description "article scientific" @default.
- Q43654264 description "article scientifique (publié 2013)" @default.
- Q43654264 description "articol științific" @default.
- Q43654264 description "articolo scientifico" @default.
- Q43654264 description "artigo científico (publicado na 2013)" @default.
- Q43654264 description "artigo científico (publicado na 2013)" @default.
- Q43654264 description "artigo científico" @default.
- Q43654264 description "artikull shkencor" @default.
- Q43654264 description "artikulong pang-agham" @default.
- Q43654264 description "artykuł naukowy" @default.
- Q43654264 description "artículo científico publicado en 2013" @default.
- Q43654264 description "artículu científicu espublizáu en 2013" @default.
- Q43654264 description "bilimsel makale" @default.
- Q43654264 description "bài báo khoa học" @default.
- Q43654264 description "mokslinis straipsnis" @default.
- Q43654264 description "naučni članak" @default.
- Q43654264 description "scienca artikolo" @default.
- Q43654264 description "scientific article" @default.
- Q43654264 description "teaduslik artikkel" @default.
- Q43654264 description "tieteellinen artikkeli" @default.
- Q43654264 description "tudományos cikk" @default.
- Q43654264 description "vedecký článok" @default.
- Q43654264 description "vetenskaplig artikel" @default.
- Q43654264 description "videnskabelig artikel (udgivet 2013)" @default.
- Q43654264 description "vitenskapelig artikkel" @default.
- Q43654264 description "vitskapeleg artikkel" @default.
- Q43654264 description "vědecký článek" @default.
- Q43654264 description "wetenschappelijk artikel" @default.
- Q43654264 description "wissenschaftlicher Artikel" @default.
- Q43654264 description "επιστημονικό άρθρο" @default.
- Q43654264 description "мақолаи илмӣ" @default.
- Q43654264 description "мақолаи илмӣ" @default.
- Q43654264 description "наукова стаття, опублікована в січні 2013" @default.
- Q43654264 description "научна статия" @default.
- Q43654264 description "научная статья" @default.
- Q43654264 description "научни чланак" @default.
- Q43654264 description "научни чланак" @default.
- Q43654264 description "գիտական հոդված" @default.
- Q43654264 description "מאמר מדעי" @default.
- Q43654264 description "سائنسی مضمون" @default.
- Q43654264 description "مقالة علمية" @default.
- Q43654264 description "مقالهٔ علمی" @default.
- Q43654264 description "২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q43654264 description "บทความทางวิทยาศาสตร์" @default.
- Q43654264 description "სამეცნიერო სტატია" @default.
- Q43654264 name "Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer" @default.
- Q43654264 name "Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer" @default.
- Q43654264 type Item @default.
- Q43654264 label "Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer" @default.
- Q43654264 label "Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer" @default.
- Q43654264 prefLabel "Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer" @default.
- Q43654264 prefLabel "Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer" @default.
- Q43654264 P1433 Q43654264-33A591D1-0D6F-4C3E-AE5D-2FEBF20B16FD @default.
- Q43654264 P1476 Q43654264-C77F0570-E521-4691-A0C5-891631AFA22B @default.
- Q43654264 P2093 Q43654264-27BE4D7E-B842-41BA-9B54-3BAD0756FAD3 @default.
- Q43654264 P2093 Q43654264-2D0D65E3-D7C8-4B53-8FB8-39A0632EB0BD @default.
- Q43654264 P2093 Q43654264-3D2615BC-F8E4-4C13-ADA8-F8AAD172A035 @default.
- Q43654264 P2093 Q43654264-6618E81E-33DA-481D-BA31-16808156ED6E @default.
- Q43654264 P2093 Q43654264-664829A1-B45B-4B3C-ABFD-1727377049C9 @default.
- Q43654264 P2093 Q43654264-9DDCCE3C-CC4C-443E-B75F-116DD80CE93C @default.
- Q43654264 P2093 Q43654264-D6B210B3-E0E1-4553-B910-3704C8A6C411 @default.
- Q43654264 P2093 Q43654264-F61E8D36-25ED-47AB-A234-40748A1D07BA @default.
- Q43654264 P304 Q43654264-9D1FDA49-C2EB-465A-83A1-AAAD04DA506D @default.
- Q43654264 P31 Q43654264-0A328B96-A08E-44A6-96B8-911C58CE448F @default.
- Q43654264 P356 Q43654264-E9702C54-FB16-4021-A742-2312770793AF @default.
- Q43654264 P433 Q43654264-E1E38E45-7336-40E3-AB77-6F9AAC8B9726 @default.
- Q43654264 P478 Q43654264-C8EC3DCD-E4D0-4BE1-A1B2-2C7252996C10 @default.
- Q43654264 P50 Q43654264-E323DBFB-FCBA-4137-B3CE-15B31E6F6C7F @default.
- Q43654264 P50 Q43654264-EB917953-D710-47FC-B6FB-8570F4BC5F1A @default.
- Q43654264 P577 Q43654264-D9870664-48F3-470E-8CB0-8ED6E8697EC3 @default.
- Q43654264 P698 Q43654264-5CA6E723-9B4D-4711-850A-EAE53CB24336 @default.
- Q43654264 P921 Q43654264-3181A781-C6FD-4C97-9E6C-EA65C73F3264 @default.
- Q43654264 P921 Q43654264-4FCDAF91-F2BE-4841-91CE-C010653471FA @default.
- Q43654264 P921 Q43654264-E7C4A457-5E71-4449-B608-4CCA7DD84412 @default.
- Q43654264 P921 Q43654264-FAFDF934-6D05-4109-B903-7C336BE021DF @default.
- Q43654264 P356 096504014X13887748696743 @default.
- Q43654264 P698 24762224 @default.
- Q43654264 P1433 Q15750114 @default.
- Q43654264 P1476 "Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer" @default.
- Q43654264 P2093 "Alberto Muñoz" @default.
- Q43654264 P2093 "Carlos García-Girón" @default.
- Q43654264 P2093 "Esther Falcó" @default.
- Q43654264 P2093 "Fernando Rivera" @default.
- Q43654264 P2093 "Iñaki Alvarez Bustos" @default.
- Q43654264 P2093 "Luis Cirera" @default.